BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       

New Appointments to JPK Instruments AG's Supervisory Board

Berlin (February 4, 2004) - Last year the Berlin-based nanobiotechnology application specialist JPK Instruments AG has appointed Dr. Andreas Eckert as the new Chairman of its Board of Supervisors.

Dr. Eckert is Chief Executive of public-traded Eckert & Ziegler Strahlen- und Medizintechnik AG, Berlin, which was founded in 1997. He is also the co-founder of numerous technology companies in Germany and abroad.

Last year JPK Instruments also appointed Roger Bendisch to the Board of Supervisors. Bendisch is director of the IBB Beteiligungsgesellschaft, Berlin, a leading venture capital investor for technology companies in Berlin.

Frank Pelzer, director and co-founder of JPK Instruments commented on the new appointments: "Our company is continually strengthening its position as one of the leading providers of atomic force microscopy application for the so-called 'soft matter' sector and the whole area of life sciences. We are very pleased to have found in Dr. Eckert and Mr Bendisch two experienced managers. Their many year's experience in corporate management and financing will secure our international standing and accelerate our business development."

167 words/1,133 characters

About JPK Instruments AG:
The innovative Berlin-based company JPK Instruments, which was founded in 1999, is among the first companies worldwide to have implemented and optimised the principle of Atomic Force Microscopy - AFM - in areas of application like soft matter and the Life Science sector. By now more than 25 highly skilled members of staff develop and manufacture Atomic Force microscopes and other instruments for nano-biotechnological applications. Numerous patents have already been filed. Around the globe there are many renowned scientific research institutes that apply this novel nano-biotechnological technique in their research programmes. JPK's technology can also be applied with non-living soft matter objects. The Company is also one of the first in the nano-biotechnology sector to receive venture capital, e.g. from IBB Beteiligungsgesellschaft mbH, tbg, "Innovationsfonds des Landes Berlin" and from participation in the programme "Futour" hosted by the Ministry of Economics and Technology. Future rounds of financing are envisaged to aid the entry into international markets and the in-house product development. The company's know-how derives from the accumulated knowledge of its founders and board membersTorsten Jähnke (physicist), Frank Pelzer (businessman) and Jörn Kamps (physicist) and the supporting supervisory board comprising of other experienced venture capitalists and entrepreneurs.

Downloads: A picture of Dr. Eckert and this text (as rtf file) in "Presse Pool": www.biocommunications.net 


Contact:
JPK Instruments AG
Dr. Gabriela Bagordo
Communication Manager
Bouchéstr. 12
D-12435 Berlin/Germany
Tel.: +49-(0)30-5331-12541
Fax.: +49-(0)30-5331-1202
eMail: bagordo@jpk.com 
web: www.jpk.com 


© BIOCOMMUNICATIONS.net GmbH, Berlin - Reprint free of charge. Please supply copy.
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright © 1997-2008 - BioPortfolio Limited.